🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This will be the first time GSK1325756 Solution for Infusion formulation th...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-12
Trial ID
NCT02169583
The purpose of this study is to evaluate the safety, pharmacokinetic and ph...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-10-31
Trial ID
NCT04460105
Treatments Being Tested
This is a Phase 3, double-blind, placebo-controlled study with the primary ...
Status
Recruiting
Location
Arkansas Children's Hospital
Start Date
2025-10-22
Trial ID
NCT07160634
This study is multicenter, double-blinded parallel group design, where part...
Status
Terminated
Location
GSK Investigational Site
Start Date
2018-04-18
Trial ID
NCT03393806
Treatments Being Tested
This FTIH study, intends to identify the doses of GSK3358699, which are wel...
Status
Terminated
Location
GSK Investigational Site
Start Date
2018-03-13
Trial ID
NCT03426995
Treatments Being Tested
This is a multicenter, randomized, double-masked, placebo-controlled, singl...
Status
Recruiting
Location
the First Hospital of China Medical University
Start Date
2026-06-30
Trial ID
NCT07622368
This multi-cohort phase I study is designed to assess the pharmacokinetics ...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-08-28
Trial ID
NCT02213029
Treatments Being Tested
Mucous membrane pemphigoid (MMP) describes a group of chronic auto-immune b...
Status
Active Not Recruiting
Location
CHU Amiens
Start Date
2019-07-11
Trial ID
NCT03295383
Treatments Being Tested
The aim of this Phase I/IIa study is to identify a safe and tolerable dosag...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-03-12
Trial ID
NCT02000817
Treatments Being Tested